Executives from consultancy firms and industry experts yesterday called for more deregulation and better government coordination to help boost the biotechnology sector.
Audrey Tseng (曾惠瑾), deputy chairwoman of PricewaterhouseCoopers (PwC) Taiwan, said that the government should lift restrictions on angel investors and facilitate tax exemptions for individual investors in biotechnology start-ups to match standards in Singapore.
Tseng told a forum organized by the government-funded Institute for Biotechnology and Medicine Industry (生技醫療產業策進會) that the proposed changes are not aimed at lowering tax obligations, but are to address investors’ concerns about prolonging the time in which tax credits can be claimed.
A precedent for tax credits for individual investors has been set in Singapore, she said, adding that the city-state is Taiwan’s main competitor in the region.
Tseng said that regulations should be eased so that funds can be reinvested in other ventures in the sector following an initial investment in a Taiwanese biotech firm by a foreign investor.
“Taiwan does not have a comprehensive platform for foreign investors to gain FINI [foreign institutional investor] or QIB [qualified institutional buyer] designation from the government,” Tseng said.
She also urged the government to improve English-language information and resources to attract more foreign capital.
Overall communication and promotion could be achieved by holding more roadshows abroad for Taiwan’s “blue chip” biotechnology companies, Tseng said.
Taipei Veterans General Hospital physician Chen Tsen-wen (陳振文) said that the government should take the lead to help companies meet compliance standards in overseas markets as they expand, especially within the scope of the “new southbound policy.”
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) secured a record 70.2 percent share of the global foundry business in the second quarter, up from 67.6 percent the previous quarter, and continued widening its lead over second-placed Samsung Electronics Co, TrendForce Corp (集邦科技) said on Monday. TSMC posted US$30.24 billion in sales in the April-to-June period, up 18.5 percent from the previous quarter, driven by major smartphone customers entering their ramp-up cycle and robust demand for artificial intelligence chips, laptops and PCs, which boosted wafer shipments and average selling prices, TrendForce said in a report. Samsung’s sales also grew in the second quarter, up
LIMITED IMPACT: Investor confidence was likely sustained by its relatively small exposure to the Chinese market, as only less advanced chips are made in Nanjing Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) saw its stock price close steady yesterday in a sign that the loss of the validated end user (VEU) status for its Nanjing, China, fab should have a mild impact on the world’s biggest contract chipmaker financially and technologically. Media reports about the waiver loss sent TSMC down 1.29 percent during the early trading session yesterday, but the stock soon regained strength and ended at NT$1,160, unchanged from Tuesday. Investors’ confidence in TSMC was likely built on its relatively small exposure to the Chinese market, as Chinese customers contributed about 9 percent to TSMC’s revenue last
Taiwan and Japan will kick off a series of cross border listings of exchange-traded funds (ETFs) this month, a milestone for the internationalization of the local ETF market, the Taiwan Stock Exchange (TWSE) said Wednesday. In a statement, the TWSE said the cross border ETF listings between Taiwan and Japan are expected to boost the local capital market’s visibility internationally and serve as a key for Taiwan becoming an asset management hub in the region. An ETF, a pooled investment security that is traded like an individual stock, can be tracked from the price of a single stock to a large and
Despite global geopolitical uncertainties and macroeconomic volatility, DBS Bank Taiwan (星展台灣) yesterday reported that its first-half revenue rose 10 percent year-on-year to a record NT$16.5 billion (US$537.8 million), while net profit surged 65 percent to an unprecedented NT$4.4 billion. The nation’s largest foreign bank made the announcement on the second anniversary of its integration with Citibank Taiwan Ltd’s (花旗台灣) consumer banking business. “Taiwan is a key market for DBS. Over the years, we have consistently demonstrated our commitment to deepening our presence in Taiwan, not only via continued investment to support franchise growth, but also through a series of bolt-on acquisitions,” DBS
RSS